Reimbursement Design and Procedure‐Level Gross Profit of Robot‐Assisted Gastrectomy in a Publicly Financed Health System: Evidence From Japan
- 1Department of Gastrointestinal and Hepato‐Biliary‐Pancreatic Surgery Faculty of Medicine University of Tsukuba Tsukuba Ibaraki Japan
Abstract
Publicly financed healthcare systems must balance technological innovation with fiscal constraints. Reimbursement mechanisms influence institutional decisions regarding the adoption of high‐cost surgical technologies. This study evaluated whether current reimbursement designs adequately reflect procedure‐level gross surgical profit of robot‐assisted gastrectomy within the Japanese National Health Insurance system. A retrospective cost analysis was conducted for curative gastric cancer surgery performed at a tertiary institution in 2024. Gross surgical profit was defined as total reimbursement minus procedure‐related costs, including consumables, robot maintenance, and labour costs. Postoperative complication‐related costs and total episode‐of‐care costs were not incorporated into the analysis. Fifty‐two gastrectomies were analysed. Open and laparoscopic distal gastrectomy generated positive gross profits, whereas robotic distal gastrectomy resulted in a negative gross margin (−¥87,075 per case). Although robotic total gastrectomy showed a positive gross profit in absolute terms, it remained substantially less profitable than open total gastrectomy. Increased procedure‐related costs associated with robotic surgery were only partially offset by higher reimbursement. Sensitivity analyses indicated that gross profit was more responsive to changes in surgical fees and material costs than to maintenance or labour costs. These findings suggest that current reimbursement increments may not fully reflect procedure‐related costs associated with robotic gastrectomy and highlight the importance of procedure‐specific reimbursement evaluation when introducing high‐cost surgical technologies into publicly financed healthcare systems.
Related
- Driving the quality of care in publicly financed health insurance: a close look at the accreditation-based incentive policy of AB-PMJAY in India
- Magnetic Duodeno-Ileostomy as a Conversion Procedure After Sleeve Gastrectomy: First Single-Centre Experience in Colombia
- Simultaneous Robot‐Assisted Distal Gastrectomy and Radical Cystectomy With a Shared Port Configuration in Situs Inversus Totalis
- Surgical procedure and efficacy of KangDuo robot-assisted pyeloplasty for horseshoe kidney
- Laparoscopic-assisted ERCP is a safe procedure with good outcomes: experience from a single high-volume upper GI unit
BibTeX
@article{akashi2026reimbursement,
title = {{Reimbursement Design and Procedure‐Level Gross Profit of Robot‐Assisted Gastrectomy in a Publicly Financed Health System: Evidence From Japan}},
author = {Yoshimasa Akashi and Koichi Ogawa and Yohei Owada and Tsuyoshi Enomoto and Kinji Furuya and Kazuhiro Takahashi and Osamu Shimomura and Yoshihiro Miyazaki and Tatsuya Oda},
journal = {The International Journal of Health Planning and Management},
year = {2026},
month = aug,
doi = {10.1002/hpm.70127},
url = {https://doi.org/10.1002/hpm.70127},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Reimbursement Design and Procedure‐Level Gross Profit of Robot‐Assisted Gastrectomy in a Publicly Financed Health System: Evidence From Japan
AU - Yoshimasa Akashi
AU - Koichi Ogawa
AU - Yohei Owada
AU - Tsuyoshi Enomoto
AU - Kinji Furuya
AU - Kazuhiro Takahashi
AU - Osamu Shimomura
AU - Yoshihiro Miyazaki
AU - Tatsuya Oda
PY - 2026
DA - 2026/08/17
JO - The International Journal of Health Planning and Management
DO - 10.1002/hpm.70127
UR - https://doi.org/10.1002/hpm.70127
AB - Publicly financed healthcare systems must balance technological innovation with fiscal constraints. Reimbursement mechanisms influence institutional decisions regarding the adoption of high‐cost surgical technologies. This study evaluated whether current reimbursement designs adequately reflect procedure‐level gross surgical profit of robot‐assisted gastrectomy within the Japanese National Health Insurance system. A retrospective cost analysis was conducted for curative gastric cancer surgery performed at a tertiary institution in 2024. Gross surgical profit was defined as total reimbursement minus procedure‐related costs, including consumables, robot maintenance, and labour costs. Postoperative complication‐related costs and total episode‐of‐care costs were not incorporated into the analysis. Fifty‐two gastrectomies were analysed. Open and laparoscopic distal gastrectomy generated positive gross profits, whereas robotic distal gastrectomy resulted in a negative gross margin (−¥87,075 per case). Although robotic total gastrectomy showed a positive gross profit in absolute terms, it remained substantially less profitable than open total gastrectomy. Increased procedure‐related costs associated with robotic surgery were only partially offset by higher reimbursement. Sensitivity analyses indicated that gross profit was more responsive to changes in surgical fees and material costs than to maintenance or labour costs. These findings suggest that current reimbursement increments may not fully reflect procedure‐related costs associated with robotic gastrectomy and highlight the importance of procedure‐specific reimbursement evaluation when introducing high‐cost surgical technologies into publicly financed healthcare systems.
SN - 0749-6753
SN - 1099-1751
ER -